J. Shapira

Expression of HLA class I and class II in gastric carcinoma in relation to pathologic stage.

A. Figer, A. Nyska, B. Klein, 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Soluble histocompatibility antigen class I in breast cancer patients in relation to tumor burden

A. Figer, B. Klein, T. Klein, 1991, Cancer.

The expression of HLA class I antigen in prostate cancer in relation to tumor differentiation and patient survival.

S. Segal, R. Gal, B. Klein, 1994, Cancer detection and prevention.

The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients.

M. Mishaeli, B. Kfir, B. Klein, 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Elevated pretreatment levels of soluble CD8 and Beta-2-microglobulin as indicators of relapse in breast-cancer patients.

A. Nyska, B. Klein, T. Klein, 1994, International Journal of Oncology.

Soluble C-erbb-2 (p185) in breast-cancer patients in relation to prognosis.

M. Mishaeli, E. Rakowski, R. Weil, 1995, Oncology reports.

Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients.

I. Cohen, Y. Beyth, J. Shapira, 1994, Gynecologic oncology.